Davidson Michael H.

Davidson Michael H. is listed in filings as Director at Tenax Therapeutics, Inc.. This profile follows SEC Form 4 activity through Mar 2, 2026, including sale activity. Recent filings connect the profile to Tenax Therapeutics, Inc. (TENX) and NewAmsterdam Pharma Co N.V. (NAMS). The current snapshot covers public activity from Jan 9, 2026 to Mar 2, 2026. Reported amounts are shown as $399.0K to $14.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.